🚀 LAUNCH OFFER ENDS
- 00Days
- 00Hrs
- 00Mins
- 00Secs
Day 2 - Wednesday 21st May - CET (Central European Time, GMT+01:00)
- Nadia Moodie - Portfolio Manager, LSX
- A look at biotech innovation in the Nordics and outlining the current investment trends in Nordic biotech
- How is the region attracting more international investors to the Nordics?
- Emerging therapeutic areas and technologies attracting investor interest
- Overview of exit strategies, IPO’s and M&A activity
- The role of digital health and AI in shaping the future of Nordic biotech
- Claus Andersson - General Partner, Sunstone Life Science Ventures
- Ester Sklarsky - Principal, Sound Bioventures
Radiopharmaceuticals are revolutionizing cancer care by offering targeted therapies and precise diagnostics. This panel discussion will bring together biotech startups, investors, and pharma leaders to explore the latest advancements, clinical trials, and commercial opportunities in this rapidly evolving field.
- Emerging trends and technological advancements in radiopharmaceutical development · Highlighting promising radiopharmaceutical startups and tech
- The role of public-private partnerships in driving innovation, accelerate development and commercialisation
- Overcoming the challenges and the long-term vision for radiopharmaceuticals in cancer car
- Jack Giles - Conference Producer, LSX
- Deploying digital health tools within large, complex health systems: key considerations for adoption and implementation
- Analysing current frameworks for digital health implementation and evaluating if they work in the real world
- Beyond the pill - examples of digital technology being used in clinical practice
- Looking to the future and effective frameworks - How can we empower healthcare professionals to adopt digital health tools effectively
- Klaudia Eriksson Philipp - Director, Global Digital Innovation & Alliances, Europe & US, Pfizer
- Shahram Sharif - CEO, Liva Healthcare
- What specific challenges are Nordic hospitals facing and how can new technologies and solutions help address them?
- How can we ensure that solutions meet the needs of both patients and healthcare providers in the Nordic region
- Practical examples where digitally connected devices and digital solutions have been implemented
- What steps can medtech & digital health companies take to build strong partnerships with Nordic hospitals and healthcare organizations?
- Hege Rob Moi - Department Head E-Health, R&D Department, Haukeland University Hospital
- Øyvind Grimsgaard - CEO, Youwell
Venture debt has emerged as a powerful financing tool for biotech startups, offering a flexible and non-dilutive approach to capital raising. This panel discussion will explore the advantages, challenges, and best practices of leveraging venture debt to fuel innovation and accelerate growth.
- Defining venture debt and how it differs from traditional equity financing
- The role of venture debt in supporting the growth of early-stage biotech companies
- Evaluating the suitability of venture debt for specific financing needs, such as clinical trial funding, facility expansion, or working capital
- Balancing venture debt with equity financing to optimize capital structure
- Key factors that venture debt providers consider when evaluating biotech startups
- Daniel Mallon - Principal, Claret Capital Partners
- Edouard Guillet - MD, IPF Partners
- Developing compelling investment theses to attract global investors and securing the funds for global expansion
- Identifying potential partners to accelerate market entry and enhance product offerings
- Negotiating favourable partnerships and licensing deals
- Building effective global teams and talent acquisition strategies
- Adapting products and services to meet the specific needs of diverse markets
- How are pharmaceutical companies integrating digital therapeutics and digital health solutions into their overall business?
- Can pharma make DTx a healthy business?
- Medication & software- Are combination products the future?
- How can digital therapeutics and digital health companies leverage collaborations with pharma for commercial success?
- Cathrine Ro Heuch - CEO & Co-Founder, Nordic Brain Tech
- Klaudia Eriksson Philipp - Director, Global Digital Innovation & Alliances, Europe & US, Pfizer
Securing funding from venture capitalists can be a challenging but rewarding endeavour. This panel discussion brings together experienced VCs to share their insights on crafting compelling pitches, building strong investor relationships, and navigating the complex fundraising process.
- The VC mindset - understanding the key criteria VCs look for in investment opportunities
- Effective strategies for reaching out to potential investors
- Key elements of a successful pitch deck, including the executive summary, market opportunity, technology, team, and financial projections
- Common pitch deck pitfalls and how to avoid them
- Strategies for handling investor pushback and negotiating favourable terms
- Svana Gunnarsdóttir - Founding Partner, Frumtak Ventures
Explore the crucial role of patient engagement in driving innovation, improving health outcomes, and building stronger relationships within the healthcare industry. This panel discussion will delve into the strategies, technologies, and ethical considerations involved in effectively engaging patients as partners in the development and delivery of healthcare solutions.
- The why – what are the benefits of patient engagement?
- The how - strategies for effective patient engagement
- Real-world examples and case studies of how biopharma, medtech and digital health companies have prioritised and implemented patient engagement strategies
- Lisbeth Snede - President, PiCC United (Patient Involvement and Collaboration Community United)
- Gaute Naespe - CEO, Inform Life
Family offices have a dynamic role in fuelling innovation across the life science sector. This discussion will explore how these influential investors are shaping the future of healthcare by providing critical early-stage funding, strategic guidance, and a long-term investment horizon. Our expert panellists will delve into the unique advantages family offices offer, the challenges they navigate, and the exciting trends driving the industry forward.
- Discussing the important role of family offices in supporting life science startups and shaping the future of healthcare
- What unique advantages do family offices offer compared to traditional venture capital firms?
- Best practice/ strategies for approaching and working with family offices
- Insights on from key family offices across biotech, medtech and digital health on their investment strategies and current portfolio
- Marie-Louise Little - Director of Strategy & Business Development, T&W Medical A/ST&W Medical